BGI

Company Snapshot

Founded: 1999
Entity Type: Public
Employees: 6000
Region: China
Headquarter: Shenzhen, China
Key Geographics: Asia Pacific, Europe, Americas
Corporate Address: Building 7, Huada Comprehensive Park, No. 21, Hong'an 3rd Street, Yantian District, Shenzhen 518083 China Tel. +86-07-55-3630-7065 www.bgi.com

Company Overview

BGI Genomics is the top global provider of comprehensive precision medicine solutions, having more than 2,300 medical facilities and clients in more than 100 countries. The company is a subsidiary of BGI Group and provides its clients with professional and reasonably priced clinical molecular diagnostic solutions as well as high-throughput sequencing (NGS) research services by using state-of-the-art sequencing and bioinformatics technologies. Additionally, BGI Genomics carries out research to improve metagenomics, reproductive health, cancer detection diagnostics and precision medicine. It benefits several healthcare facilities, academic institutions, and other public partners. The corporation operates throughout Asia-Pacific, Europe, North America, the Middle East, and Africa. The main office of BGI Genomics is located in Shenzhen, Guangdong, China. BGI holds the flag for being a pioneer in the field of multiomics and offers services to accelerate drug development and basic research projects. These include a range of advanced genomics, proteomics, and metabolomics solutions.

BGI In Reports

Global DNA Sequencing: Research, Applied and Clinical Markets

BCC Research Market Analyst says global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a CAGR of 18.6%.

Rare Disease Diagnostics: Technologies and Global Markets

BCC Research Report: Dive into Rare Disease Diagnostics Market report includes applications, industries, and services is given for 2023 and 2024, and then forecast through 2029.

RNA Sequencing: Technologies and Global Markets

BCC Research Market Analyst says global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a CAGR of 19.1%.

Applications/End User Industries

  • Next Generation Sequencing
  • Molecular Testing
  • Bioinformatics
  • Proteomics
  • Genetic Tests
  • Sequencing Services
  • Sequencing Technology
  • Analytical Services
  • RNA Sequencing